Rules of Origin for phenazone (antipyrine) and its derivatives — Dubai (UAE) to India
HS 29331100 · HETEROCYCLIC COMPOUNDS WITH NITROGEN · Rules of Origin & preferential rate
Data last updated: · MFN duty & IGST verified against ICEGATE (Indian Customs EDI). Rules of Origin per CEPA Annex 3B. Verify your exact HS line before filing.
- CEPA eligible
- Yes
- Value addition (RVC)
- 40%
- Tariff-classification change
- CTSH Annex 3B rule set at chapter level — it covers the whole chapter, not this code alone
- MFN → CEPA basic duty
- 7.5% → 0%
Rule of Origin (CEPA Annex 3B, primary source): CTSH + VA 40% (CEPA Annex 3B Product-Specific Rule; tariff-shift AND value addition both required).
Qualifying under the Rules of Origin
To claim the CEPA preference on phenazone (antipyrine) and its derivatives (HS 29331100), the goods must qualify as UAE-originating. The Product-Specific Rule (Annex 3B) is "CTSH + VA 40% (CEPA Annex 3B Product-Specific Rule; tariff-shift AND value addition both required)": the goods must undergo a change of tariff sub-heading (CTSH) AND add at least 40% regional value content — both conditions, not either/or. Read that rule for what it is: Annex 3B supplies it at chapter level, so it governs hundreds of eight-digit codes rather than this one. It is the correct rule to apply, and it is also the place to check for a more specific carve-out before committing to a claim. Phenazone is a pharmaceutical intermediate and active ingredient with a long-established analgesic history, supplied into India's formulation industry. CEPA removes the 7.5% MFN duty. Pharmaceutical intermediates must meet the 40% regional-value-content rule, and repackaged API sourced from Asia and shipped via the UAE does not qualify — a frequent misconception in the pharma trade, where regional distribution hubs are routinely mistaken for origin. Beyond origin, CDSCO governs admissibility and dominates the timeline: import registration and a licence are required for the product and the manufacturing site together, with GMP evidence, and clearance depends on them being in place before arrival rather than applied for afterwards. The useful efficiency here is that both processes interrogate the same fact. Align the manufacturing-site evidence used for CDSCO registration with the origin declaration filed for the CEPA claim, because an inconsistency between them undermines each independently. A valid Certificate of Origin filed through the eCoO 2.0 system must accompany the shipment; without it, customs charges the 7.5% MFN rate instead of the preference.
Check your own figures in the Rules of Origin (RVC) qualifier. Qualifying is only half of it — the preference is claimed with a Certificate of Origin, issued in the UAE before shipment or retrospectively within 12 months.
Frequently asked questions
- Does phenazone (antipyrine) and its derivatives qualify for India–UAE CEPA?
- Yes, if it meets the Annex 3B Product-Specific Rule "CTSH + VA 40% (CEPA Annex 3B Product-Specific Rule; tariff-shift AND value addition both required).": it must BOTH change tariff classification (CTSH) AND add at least 40% regional value content — both conditions are required, not either/or.
- What is the Rule of Origin for phenazone (antipyrine) and its derivatives?
- Per CEPA Annex 3B: CTSH + VA 40% (CEPA Annex 3B Product-Specific Rule; tariff-shift AND value addition both required).. RVC% = [(FOB − value of non-originating materials) / FOB] × 100 (FOB basis).
- What proof is needed at import?
- A preferential Certificate of Origin filed through eCoO 2.0, presented at customs before clearance. Without it, the 7.5% MFN duty applies.